Robinetinidol‑flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase

  • Authors:
    • Hai Niu
    • Yu Chao
    • Ke Li
    • Junxiang Li
    • Weihong Gong
    • Wen Huang
  • View Affiliations

  • Published online on: October 23, 2014     https://doi.org/10.3892/mmr.2014.2758
  • Pages: 561-566
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Robinetinidol‑(4β,2')‑tetrahydroxy‑flavone (RBF) is an oligomeric condensed polyphenol that has been shown to exhibit anti‑obesity effects in mice. However, little is know regarding its effect on cholesterol synthesis. The present study therefore aimed to investigate the effect of RBF on cholesterol synthesis. It was determined that RBF decreased serum total cholesterol and low density lipoprotein cholesterol in rats by 25.9 and 50.8%, respectively (P<0.001). These results strengthen evidence for the hypothesis that RBF exerts anti‑atherogenic effects in vivo. Furthermore, RBF decreased cholesterol synthesis by 72%, when measured using a 3 h period of radiolabeled acetate incorporation into cholesterol, but not when using radiolabelled mevalonate, suggesting that RBF‑mediated inhibition occurred largely at or above the level of 3‑hydroxy‑3‑methylglutaryl‑coenzymeA (HMG‑CoA) reductase. The mechanism by which RBF inactivates HMG‑CoA reductase may be attributed to the induction of phosphorylation of adenosine monophosphate (AMP)‑kinase, since these results showed that RBF increased phosphorylation of AMP‑kinase and HMG‑CoA reductase by 2.1‑ and 3.2‑fold, respectively, within 30 min of addition. These results suggest that RBF may be a potential therapeutic agent for hypercholesteremia.
View Figures
View References

Related Articles

Journal Cover

January-2015
Volume 11 Issue 1

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Niu H, Chao Y, Li K, Li J, Gong W and Huang W: Robinetinidol‑flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase. Mol Med Rep 11: 561-566, 2015.
APA
Niu, H., Chao, Y., Li, K., Li, J., Gong, W., & Huang, W. (2015). Robinetinidol‑flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase. Molecular Medicine Reports, 11, 561-566. https://doi.org/10.3892/mmr.2014.2758
MLA
Niu, H., Chao, Y., Li, K., Li, J., Gong, W., Huang, W."Robinetinidol‑flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase". Molecular Medicine Reports 11.1 (2015): 561-566.
Chicago
Niu, H., Chao, Y., Li, K., Li, J., Gong, W., Huang, W."Robinetinidol‑flavone attenuates cholesterol synthesis in hepatoma cells via inhibition of 3‑hydroxy‑3‑methylglutaryl‑coenzyme A reductase". Molecular Medicine Reports 11, no. 1 (2015): 561-566. https://doi.org/10.3892/mmr.2014.2758